Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report. 1998

D Ducloux, and V Fournier, and C Bresson-Vautrin, and J M Rebibou, and C Billerey, and Y Saint-Hillier, and J M Chalopin
Department of Nephrology and Renal Transplantation, Hopital Saint Jacques, Besançon, France.

BACKGROUND There is a great concern over cyclosporine (CsA) nephrotoxicity in renal transplant recipients, and the effects of conversion from CsA to azathioprine (AZA) remain controversial. Large studies have demonstrated that mycophenolate mofetil (MMF), the morpholinoethyl ester of mycophenolic acid, is superior to AZA as a posttransplant immunosuppressant. METHODS Six patients with isolated biopsy-proven CsA nephrotoxicity were converted from CsA-AZA to MMF. RESULTS Mean follow-up was 12+/-2 months. No patient experienced acute rejection. The mean serum creatinine concentration decreased from 225+/-58 to 159+/-66 micromol/L (P<0.0005). Hyperlipidemia and blood pressure improved after CsA withdrawal. CONCLUSIONS In a selected transplant population with biopsy-proven CsA nephrotoxicity, CsA withdrawal with a concomitant switch from AZA to MMF seems to be safe and allows a significant improvement of renal function.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D011182 Postoperative Care The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed) Care, Postoperative,Postoperative Procedures,Procedures, Postoperative,Postoperative Procedure,Procedure, Postoperative
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Ducloux, and V Fournier, and C Bresson-Vautrin, and J M Rebibou, and C Billerey, and Y Saint-Hillier, and J M Chalopin
September 1999, Transplantation proceedings,
D Ducloux, and V Fournier, and C Bresson-Vautrin, and J M Rebibou, and C Billerey, and Y Saint-Hillier, and J M Chalopin
January 2000, Transplant international : official journal of the European Society for Organ Transplantation,
D Ducloux, and V Fournier, and C Bresson-Vautrin, and J M Rebibou, and C Billerey, and Y Saint-Hillier, and J M Chalopin
January 2001, Transplant international : official journal of the European Society for Organ Transplantation,
D Ducloux, and V Fournier, and C Bresson-Vautrin, and J M Rebibou, and C Billerey, and Y Saint-Hillier, and J M Chalopin
November 1999, Transplantation proceedings,
D Ducloux, and V Fournier, and C Bresson-Vautrin, and J M Rebibou, and C Billerey, and Y Saint-Hillier, and J M Chalopin
March 2005, Transplantation proceedings,
D Ducloux, and V Fournier, and C Bresson-Vautrin, and J M Rebibou, and C Billerey, and Y Saint-Hillier, and J M Chalopin
April 2006, Nephrology (Carlton, Vic.),
D Ducloux, and V Fournier, and C Bresson-Vautrin, and J M Rebibou, and C Billerey, and Y Saint-Hillier, and J M Chalopin
July 1999, Transplantation,
D Ducloux, and V Fournier, and C Bresson-Vautrin, and J M Rebibou, and C Billerey, and Y Saint-Hillier, and J M Chalopin
December 2000, Clinical transplantation,
D Ducloux, and V Fournier, and C Bresson-Vautrin, and J M Rebibou, and C Billerey, and Y Saint-Hillier, and J M Chalopin
April 2008, Transplantation proceedings,
D Ducloux, and V Fournier, and C Bresson-Vautrin, and J M Rebibou, and C Billerey, and Y Saint-Hillier, and J M Chalopin
September 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Copied contents to your clipboard!